Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Critical Illness
  • Hyperglycemia
Type
Interventional
Phase
Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Outcomes Assessor)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT03665207
Collaborators
  • Universitaire Ziekenhuizen Leuven
  • Research Foundation Flanders
Investigators
Study Director: Greet Van den Berghe, MD, PhD KU Leuven Principal Investigator: Jan Gunst, MD, PhD KU Leuven